|

Hativ® ELectrocardiogram Monitoring on Patients With Suspected Arrhythmia

RECRUITINGN/ASponsored by Wonju Severance Christian Hospital
Actively Recruiting
PhaseN/A
SponsorWonju Severance Christian Hospital
Started2024-02-22
Est. completion2025-12-31
Eligibility
Age19 Years+
Healthy vol.Accepted

Summary

HELP-A study is a single-center, randomized, controlled trial. A total of 588 patients enrolled during the 2 years of enrollment period and followed for 1 month of follow-up period. This study aims to compare diagnostic yield between continuous ECG Patch and intermittent handheld ECG in patients with arrhythmia symptoms.

Eligibility

Age: 19 Years+Healthy volunteers accepted
Inclusion Criteria:

* Patients who have arrhythmia symptoms but are not diagnosed on a 12-lead electrocardiogram and require additional tests.
* Patients who can use a smartphone

Exclusion Criteria:

* Patients who have cardiac implantable electronic devices(CIEDs)
* Patients who can't use handheld ECG

Conditions2

ArrhythmiaHeart Disease

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.